Dr. Lal PathLabs informs about press release

15 Apr 2025 Evaluate

Pursuant to Regulation 30 of the Listing Regulations, Dr. Lal PathLabs has informed that it enclosed the Press Release titled ‘Dr. Lal PathLabs Becomes South Asia’s First Diagnostic Chain to Launch Advanced Test for Amyloidosis’.

The above information is a part of company’s filings submitted to BSE.

Dr. Lal Pathlabs Share Price

3025.95 -28.50 (-0.93%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×